The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein

Overview of attention for article published in Methods in Cell Science, January 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 74 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

NOVEL VECTOR AND USE THEREOF

Application EP-3805396-A4

European Patent Office

GALACTOSE-ALPHA-1,3-GALACTOSE-CONTAINING N-GLYCANS IN GLYCOPROTEIN PRODUCTS DERIVED FROM…

Grant EP-2389586-B2

European Patent Office

PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS

Application WO-2014097113-A2

World Intellectual Property Organisation (WIPO)

FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF

Application WO-2013007563-A1

World Intellectual Property Organisation (WIPO)

REGULATION OF TRANSLATION OF EXPRESSED GENES

Application WO-2012044171-A1

World Intellectual Property Organisation (WIPO)